Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

37 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Antithrombotic strategies in elderly patients with atrial fibrillation revascularized with drug-eluting stents: PACO-PCI (EPIC-15) registry.
de la Torre Hernandez JM, Ferreiro JL, Lopez-Palop R, Ojeda S, Marti D, Avanzas P, Linares JA, Diego A, Amat IJ, Telleria M, Cid B, Otaegui I, Lozano I, Serrano D, Pinar E, González-Manzanares R, Concepción-Suárez R, Pascual I, Urbano C, Sadaba M, Garcia-Guimaraes M, Andres-Cordon JF, Hernandez F, Sanchez-Recalde A, Garilleti C, Perez de Prado A. de la Torre Hernandez JM, et al. Among authors: otaegui i. Int J Cardiol. 2021 Sep 1;338:63-71. doi: 10.1016/j.ijcard.2021.05.036. Epub 2021 May 29. Int J Cardiol. 2021. PMID: 34062196
One-year outcomes with angiographic follow-up of paclitaxel-eluting balloon for the treatment of in-stent restenosis: insights from Spanish multicenter registry.
Vaquerizo B, Serra A, Miranda-Guardiola F, Martínez V, Antoni Gómez-Hospital J, Iñiguez A, Fernández E, Ramón Rumoroso J, Bosa F, Otaegui I. Vaquerizo B, et al. Among authors: otaegui i. J Interv Cardiol. 2011 Dec;24(6):518-28. doi: 10.1111/j.1540-8183.2011.00667.x. Epub 2011 Sep 15. J Interv Cardiol. 2011. PMID: 21917013 Free article.
Prognostic impact of tissue factor pathway on long-term ischemic events of ST-elevated myocardial infarction treated with a primary percutaneous coronary intervention.
Sambola A, García Del Blanco B, Francisco J, Figueras J, Martí G, Roca-Luque I, Otaegui I, García-Dorado D. Sambola A, et al. Among authors: otaegui i. Int J Cardiol. 2013 Oct 3;168(3):2916-2918. doi: 10.1016/j.ijcard.2013.03.188. Epub 2013 May 1. Int J Cardiol. 2013. PMID: 23642812 No abstract available.
Intracoronary injection of adenosine before reperfusion in patients with ST-segment elevation myocardial infarction: a randomized controlled clinical trial.
Garcia-Dorado D, García-del-Blanco B, Otaegui I, Rodríguez-Palomares J, Pineda V, Gimeno F, Ruiz-Salmerón R, Elizaga J, Evangelista A, Fernandez-Avilés F, San-Román A, Ferreira-González I. Garcia-Dorado D, et al. Among authors: otaegui i. Int J Cardiol. 2014 Dec 20;177(3):935-41. doi: 10.1016/j.ijcard.2014.09.203. Epub 2014 Oct 7. Int J Cardiol. 2014. PMID: 25449504 Clinical Trial.
Long-Term Results of Everolimus-Eluting Stents Versus Drug-Eluting Balloons in Patients With Bare-Metal In-Stent Restenosis: 3-Year Follow-Up of the RIBS V Clinical Trial.
Alfonso F, Pérez-Vizcayno MJ, García Del Blanco B, Otaegui I, Masotti M, Zueco J, Veláquez M, Sanchís J, García-Touchard A, Lázaro-García R, Moreu J, Bethencourt A, Cuesta J, Rivero F, Cárdenas A, Gonzalo N, Jiménez-Quevedo P, Fernández C; RIBS V Study Investigators. Alfonso F, et al. Among authors: otaegui i. JACC Cardiovasc Interv. 2016 Jun 27;9(12):1246-1255. doi: 10.1016/j.jcin.2016.03.037. Epub 2016 Jun 20. JACC Cardiovasc Interv. 2016. PMID: 27339840 Free article. Clinical Trial.
Three- and 6-month optical coherence tomographic surveillance following percutaneous coronary intervention with the Angiolite® drug-eluting stent: The ANCHOR study.
Puri R, Otaegui I, Sabaté M, Serra-Peñaranda A, Puigfel M, Perez de Prado A, Nombela-Franco L, de la Torre Hernandez JM, Ortas Nadal R, Iniguez-Romo A, Jiménez G, Fernandez-Vazquez F, Cuellas-Ramon C, Gonzalo N, Alfonso Jiménez Diaz V, Duocastella L, Molina M, Amoros M, Perez I, Barria Perez A, Pelletier Beaumont E, Nicholls SJ, Garcia Del Blanco B, Rodés-Cabau J. Puri R, et al. Among authors: otaegui i. Catheter Cardiovasc Interv. 2018 Feb 15;91(3):435-443. doi: 10.1002/ccd.27189. Epub 2017 Jul 14. Catheter Cardiovasc Interv. 2018. PMID: 28707379 Clinical Trial.
Device specificity of vascular healing following implantation of bioresorbable vascular scaffolds and bioabsorbable polymer metallic drug-eluting stents in human coronary arteries: the ESTROFA OCT BVS vs. BP-DES study.
de la Torre Hernandez JM, Gonzalo N, Otaegui I, Rumoroso JR, Gutiérrez H, Alfonso F, Marti G, Serrador-Frutos AM, Brugaletta S, Gomez Menchero A, Garcia Camarero T, Biagioni C, Escaned J. de la Torre Hernandez JM, et al. Among authors: otaegui i. EuroIntervention. 2018 Dec 20;14(12):e1295-e1303. doi: 10.4244/EIJ-D-17-00952. EuroIntervention. 2018. PMID: 29901443 Free article.
Bioresorbable scaffolds versus permanent sirolimus-eluting stents in patients with ST-segment elevation myocardial infarction: vascular healing outcomes from the MAGSTEMI trial.
Gomez-Lara J, Ortega-Paz L, Brugaletta S, Cuesta J, Romaní S, Serra A, Salinas P, García Del Blanco B, Goicolea J, Hernandez-Antolín R, Antuña P, Romaguera R, Regueiro A, Rivero F, Cequier À, Alfonso F, Gómez-Hospital JA, Sabaté M; Collaborators. Gomez-Lara J, et al. EuroIntervention. 2020 Dec 4;16(11):e913-e921. doi: 10.4244/EIJ-D-20-00198. EuroIntervention. 2020. PMID: 32310130 Free article. Clinical Trial.
Comparison of One-Year Outcomes Between the ihtDEStiny BD Stent and the Durable-Polymer Everolimus- and Zotarolimus-Eluting Stents: A Propensity-Score-Matched Analysis.
de la Torre Hernández JM, Ocaranza Sanchez R, Santas Alvarez M, Pinar Bermudez E, Hurtado Martinez JA, Garcia Del Blanco B, Otaegui I, Fernandez Nofrerias E, Carrillo Suarez X, Sainz Laso F, Casanova Sandoval JM, Rivera Aguilar PK, Cid B, Trillo R, Lozano Ruiz-Poveda F, Peral Disdier V, Telleria M, Torres A, Sanchis J, Oliva X, Freixa X, Sadaba Sagredo M, Moreu J, Hernández F. de la Torre Hernández JM, et al. Among authors: otaegui i. Cardiovasc Revasc Med. 2021 Oct;31:1-6. doi: 10.1016/j.carrev.2020.09.046. Epub 2020 Oct 3. Cardiovasc Revasc Med. 2021. PMID: 33060037
First-in-Man Evaluation of a Sirolimus-Eluting Stent With Abluminal Fluoropolymeric/Triflusal Coating With Ultrathin Struts by OCT at 9 Months' Follow-Up: The PROMETHEUS Study.
de la Torre Hernandez JM, Otaegui I, Subinas A, Gomez-Menchero A, Moreno R, Rondan J, Muñoz-Garcia E, Sainz-Laso F, Garcia Del Blanco B, Rumoroso JR, Diaz JF, Berenguer A, Gomez-Lara J, Zueco J. de la Torre Hernandez JM, et al. Among authors: otaegui i. Cardiovasc Revasc Med. 2021 Nov;32:18-24. doi: 10.1016/j.carrev.2020.12.025. Epub 2020 Dec 29. Cardiovasc Revasc Med. 2021. PMID: 33386256
37 results